Clinical Trials Browser

Phase 2/3 × OTHER × Grafton demineralized bone matrix gel × Clear all

NCT00851162 2012-11-28

Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions

Phase 2/3 Withdrawn

Bone Neoplasms